Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-60.10	23.78	59.61
Graham Fair Price	38.78	21777.57	15691.72
PEG	-63.10	0.05	0.14
Price/Book	-26.21	0.53	0.72
Price/Cash Flow	-48.65	26.88	52.35
Prices/Earnings	-58.24	5.64	13.50
Price/Sales	-31.79	4.69	6.88
Price/FCF	-48.65	26.88	52.35
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	183.28	0.21	0.07
Operating Margin	752.70	0.17	0.02
ROA	72.48	0.02	0.01
ROE	0.01	0.02	76.69
ROIC	< 0.005	0.02	819.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.06	0.54	-88.30
Dividends QOQ	-0.31	-1.00	-227.32
EBIT QOQ	-0.44	8.63	1850.29
EPS QOQ	0.99	1.12	13.16
FCF QOQ	16.41	0.50	-96.95
Revenue QOQ	-0.03	0.13	331.65
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	17.08	17.73	3.78
Days Sales Outstanding (DSO)	42.91	43.51	1.39
Inventory Turnover	5.27	5.08	-3.64
Debt/Capitalization	0.12	0.13	3.35
Quick Ratio	6.37	5.19	-18.53
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	28676.62	29940.30	4.41
Cash	17062.56	18159.86	6.43
Capex	-421.20	-607.17	-44.15
Free Cash Flow	393.52	590.38	50.02
Revenue	2993.76	3381.33	12.95
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	6.59	5.40	-18.02
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.55	6.29	13.37
Naive Interpretation	Member

06 - Financial Health · Bad

Rating